Skip to main content
Clinical Trials/NCT03213106
NCT03213106
Unknown
Not Applicable

Effects of Cerebellar Transcranial Magnetic Stimulation in Cerebellar Ataxias

University of Sao Paulo General Hospital1 site in 1 country30 target enrollmentDecember 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebellar Ataxia
Sponsor
University of Sao Paulo General Hospital
Enrollment
30
Locations
1
Primary Endpoint
Percent Change From Baseline to Post Treatment on the Scale for the Assessment and Rating of Ataxia (SARA)
Last Updated
8 years ago

Overview

Brief Summary

Cerebellar ataxias are a group of disorders caused by cerebellar affections, for which currently no specific treatment is available. Some limited studies verified the effects of cerebellar transcranial magnetic stimulation (TMS) on ataxic symptoms, with good results. So far it is not known which patients could benefit. Our hypothesis is that cerebellar TMS could improve ataxic symptoms in some patients.

Detailed Description

Thirty patients with cerebellar ataxia will be included in our protocol. Ataxia might be due to several aetiologies, from degenerative to genetic and vascular diseases. Patients will be submitted to a neuronavigation protocol for the precise location of the dentate nucleus contralateral to the most symptomatic side. After that, participants will be randomly assigned to 5 active or 5 placebo sessions of 1Hz TMS over the located area. After the first 5 sessions and a period of at least 4 weeks washout, patients will cross over and receive other 5 sessions, active or sham. Clinical and video evaluations will be conducted before and after active and sham cluster of sessions.

Registry
clinicaltrials.gov
Start Date
December 1, 2016
End Date
December 1, 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rubens Gisbert Cury

Dr Rubens Gisbert Cury

University of Sao Paulo General Hospital

Eligibility Criteria

Inclusion Criteria

  • identification of cerebellar ataxia based on neurologic examination
  • no improvement after rehabilitation
  • symptoms onset of at least 6 months

Exclusion Criteria

  • Younger than 18 months
  • Pregnant or breastfeeding women
  • Participation in other clinical trials

Outcomes

Primary Outcomes

Percent Change From Baseline to Post Treatment on the Scale for the Assessment and Rating of Ataxia (SARA)

Time Frame: Day 1 (baseline), day 5 (after 5th TMS session, active or sham), day 33 (new baseline after TMS wash out) and day 38 (after 10th TMS session, active or sham)

Assess 8 items: gait, stance, sitting, speech, dysmetria, kinetic tremor, pro- and supinations of the hand, and the heel-shin slide. Each item is scored by the physician on a 4 to 8 numerical scale based upon the amount of dysfunction observed while performing the task. The maximum possible score for the total scale is 40. Lower scores of SARA represents better task performance.

Study Sites (1)

Loading locations...

Similar Trials